News Archives for July 2018

Recent News

ASGCT Submits Comment on CAR T-Cell Therapy Coverage and Reimbursement
July 26, 2018
ASGCT News Policy Updates

ASGCT submitted comments last month to the Centers for Medicare & Medicaid Services (CMS) on Medicare coverage and reimbursement of CAR T-cell therapies as part of the Society’s effort to improve access to approved gene therapies.

Remembering Dr. George Stamatoyannopoulos
July 25, 2018
ASGCT News

Scientist and physician George "Dr. Stam" Stamatoyannopoulos, M.D., Dr. Sci, who conceptualized and helped create the American Society of Gene & Cell Therapy in 1996, died June 16, 2018. To those who knew Dr. Stamatoyannopoulos, he was a friend, mentor, leader, and brilliant scientist.

Six New FDA Guidance Documents Open for Comment
July 19, 2018
Policy Updates

With new FDA guidance drafts addressing hemophilia, retinal disorders, rare diseases, and manufacturing standards, ASGCT will be evaluating the specific content of the guidance documents leading up to the September 13 liaison meeting with the FDA. The Society will provide recommendations related to the details of these guidance documents.

The Near Future of Gene Therapy Regulation
July 02, 2018
Policy Updates

In a meeting with ASGCT organizational partner Research America, Peter Marks, M.D., Ph.D., director of the FDA’s Center for Biologics Evaluation and Research (CBER), discussed FDA guidance documents and elaborated on the agency’s interaction with their European counterparts in relation to gene and cell therapy.

2019
22nd Annual Meeting
April 29 – May 2 | Washington D.C.
Close